Aryl aminopyrimidine compounds and uses thereof as well as pharmaceutical compositions and pharmaceutical compositions prepared therefrom

The present invention discloses a pharmaceutically aryl aminopyrimidine compound having inhibitory effect on EGFR tyrosine kinase and its pharmaceutically acceptable salts, stereoisomer, solvate or prodrug thereof, as shown in Formula I, wherein each see the definition of group specification. Further, the present invention also discloses a pharmaceutical composition comprising the compound, pharmaceutical compositions and uses thereof.